Remission Medical

Remission Medical

Private
VirginiaHealthcare & Life Scienceshttps://remissionmedical.com/

Last Round

Series A

Apr 9, 2026

Total Funding Raised

$5M

Company Overview

Remission Medical is a healthcare company that provides a virtual rheumatology platform to expand access to care by partnering with health systems and specialty practices.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Vertical SaaS, Workflow Automation, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

virtual rheumatologyvirtual specialty carecapacity-extension modelcare-as-a-servicehealth system partnershiptelemedicineclinical workforce platformprovider enablementEHR integrationvirtual-first carehealthcare automationmedical AIreferral leakageeConsults

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Remission Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Remission Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AApr 9, 2026

Key People

Founding team and executive leadership

Blake Wehman

Founder CEO

Founding Team

Tyler Beard

Chief Technology Officer

Executive Team

Bhavika Amin

Chief Clinical Officer, Chief Operating Officer

Executive Team

Remission Medical Investors

Notable investors and investment history

InvestorRounds
Blue Heron CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 9, 2026

    $5M round completed.

  • Dec 24, 2025

    Grew 21% QoQ from 19 to 23 employees.

Remission Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Remission Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Remission Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersVirginia
Employee Range23
Year Founded2022
Last FundingApr 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.